🔗 Permalink

Inventor profile of:

Seth Lederman

City:

NEW York, New York

Country:

United States

Published Applications:

35

Last publication date:

2025-08-21

Top Assignees for applications by Seth Lederman

The entities that hold a legal rights for patent applications filed by inventor Lederman Seth:

Tonix Pharma Holdings Limited 5 Hamilton, Bermuda
TONIX Pharmaceuticals Holding Corp 5 New York, NY United States
TONIX PHARMACEUTICALS INC. 4 NEW YORK, NY United States
Tonix Pharma Holdings Limited 3 Dublin, Ireland
Eleison Pharmaceuticals LLC 2 Princeton, NJ United States
The Trustees of Columbia University in the City of New York 2 New York, NY United States
FOLLICA, INC. 2 Boston, MA United States
TONIX PHARMACEUTICALS, INC. 1 Saddle Brook, NJ United States
Krele Pharmaceuticals, Inc. 1 Saddle Brook, NJ United States
TONIX PHARMA HOLDINGS LIMITED (BERMUDA) 1 Hamilton, Bermuda
The Trustees of Columbia University 1 New York, NY United States

Recent patent applications by Lederman Seth

Seth Lederman from NEW York, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-21

US20250262168A1

Human necessities

COMBINATION THERAPEUTIC REGIMENS WITH 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL

#2 | 2025-03-06

US20250073204A1

Human necessities

ANALOGS OF CYCLOBENZAPRINE AND AMITRYPTILENE

#3 | 2023-05-18

US20230149348A1

Human necessities

Analogs of cyclobenzaprine and amitryptilene

#4 | 2022-06-23

US20220193383A1

Human necessities

Methods for treating baldness and promoting hair growth

#5 | 2022-06-16

US20220185785A1

Chemistry; metallurgy

INHIBITORS OF CD40-CD154 BINDING

#6 | 2022-05-12

US20220142941A1

Human necessities

COMBINATION THERAPEUTIC REGIMENS WITH 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL

#7 | 2021-05-06

US20210128495A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING FATIGUE ASSOCIATED WITH DISORDERED SLEEP USING VERY LOW DOSE CYCLOBENZAPRINE

#8 | 2020-07-23

US20200230104A1

Human necessities

Analogs of cyclobenzaprine and amitriptyline

#9 | 2019-12-19

US20190381296A1

Human necessities

Methods for treating baldness and promoting hair growth

#10 | 2019-11-28

US20190358177A1

Human necessities

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

#11 | 2019-11-07

US20190336458A1

Human necessities

Eutectic formulations of cyclobenzaprine hydrochloride

#12 | 2019-06-20

US20190185438A1

Chemistry; metallurgy

SALTS AND POLYMORPHS OF ESREBOXETINE

#13 | 2019-06-13

US20190175525A1

Human necessities

Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

#14 | 2018-09-06

US20180251736A1

Chemistry; metallurgy

Synthetic chimeric poxviruses

#15 | 2018-07-12

US20180193288A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING SYMPTOMS ASSOCIATED WITH POST-TRAUMATIC STRESS DISORDER USING CYCLOBENZAPRINE

#16 | 2017-10-05

US20170281568A1

Human necessities

Eutectic formulations of cyclobenzaprine hydrochloride

#17 | 2017-03-09

US20170065538A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING FATIGUE ASSOCIATED WITH DISORDERED SLEEP USING VERY LOW DOSE CYCLOBENZAPRINE

#18 | 2015-09-17

US20150258197A1

Human necessities

EUTECTIC ISOMETHEPTENE MUCATE

#19 | 2015-03-05

US20150065581A1

Human necessities

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

#20 | 2014-07-31

US20140212486A1

Chemistry; metallurgy

Isometheptene isomer

#21 | 2014-06-19

US20140171515A1

Human necessities

COMPOSITIONS AND METHODS FOR TRANSMUCOSAL ABSORPTION

#22 | 2014-03-20

US20140079686A1

Human necessities

Methods For Treating Baldness And Promoting Hair Growth

#23 | 2013-06-27

US20130165511A1

Human necessities

TREATMENT FOR COCAINE ADDICTION

#24 | 2012-09-13

US20120232159A1

Human necessities

Methods and compositions for treating depression using cyclobenzaprine

#25 | 2012-04-26

US20120101154A1

Human necessities

Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism

#26 | 2011-12-29

US20110319389A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING FATIGUE ASSOCIATED WITH DISORDERED SLEEP USING VERY LOW DOSE CYCLOBENZAPRINE

#27 | 2011-05-26

US20110124656A1

Human necessities

Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine

#28 | 2009-01-01

US20090005441A1

Human necessities

Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism

#29 | 2007-05-17

US20070110685A1

Human necessities

Combination therapy for the treatment of immunoinflammatory disorders

#30 | 2006-07-04

US8476649

Method for inhibiting inflammation with an antibody that binds the 5C8 protein

#31 | 2006-05-25

US20060110392A1

Chemistry; metallurgy

Murine monoclonal antibody (5c8) recognizes T-B cell activating molecule (T-BAM) (CD40 LIGAND) on the surface of T-lymphocytes, compositions containing same and methods of use

#32 | 2006-02-16

US20060035823A1

Chemistry; metallurgy

Isolated fragments of p62 nucleoporin and uses thereof

#33 | 2005-06-02

US20050118166A1

Therapeutic applications for the anti-T-BAM (CD40-1) monoclonal antibody 5C8

#34 | 2005-02-17

US20050037005A1

Chemistry; metallurgy

5c8 Antigen

#35 | 2005-02-01

US9950902

TRAF-3 deletion isoforms and uses thereof

InventorID:

313798 ⎘